12:00 AM
 | 
Sep 22, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Seasonal influenza VLP vaccine: Phase IIa started

Novavax began a placebo-controlled Phase lla trial to evaluate single injection of 5, 15 or 30 µg of the Seasonal influenza VLP vaccine in about 300 healthy...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >